{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bempedoic+Acid", "query": { "intervention": "Bempedoic Acid" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 21, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bempedoic+Acid&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T04:30:14.926Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03531905", "title": "Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2", "Cholesterolemia" ], "interventions": [ { "name": "Bempedoic acid + Ezetimibe FDC Oral Tablet", "type": "DRUG" }, { "name": "Ezetimibe 10 mg Oral Tablet", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Esperion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 242, "start_date": "2018-05-09", "completion_date": "2019-06-18", "has_results": true, "last_update_posted_date": "2020-04-09", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 4, "location_summary": "Lincoln, California • Miami, Florida • Louisville, Kentucky + 1 more", "locations": [ { "city": "Lincoln", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Suffolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03531905" }, { "nct_id": "NCT06742853", "title": "A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "AZD0780", "type": "DRUG" }, { "name": "Ezetimibe", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Bempedoic Acid", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 81, "start_date": "2024-12-20", "completion_date": "2025-10-29", "has_results": false, "last_update_posted_date": "2025-11-10", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 2, "location_summary": "Glendale, California • Brooklyn, Maryland", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06742853" }, { "nct_id": "NCT06280976", "title": "Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Atherosclerosis", "Heart Attack" ], "interventions": [ { "name": "Statin", "type": "DRUG" }, { "name": "Aspirin tablet", "type": "DRUG" }, { "name": "Nexlizet", "type": "DRUG" }, { "name": "LEQVIO", "type": "DRUG" }, { "name": "Vascepa", "type": "DRUG" }, { "name": "Jardiance", "type": "DRUG" }, { "name": "Colchicine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Louisville", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2024-03-01", "completion_date": "2025-01-01", "has_results": false, "last_update_posted_date": "2025-03-17", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT06280976" }, { "nct_id": "NCT06450366", "title": "A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Enlicitide", "type": "DRUG" }, { "name": "Ezetimibe", "type": "DRUG" }, { "name": "Bempedoic Acid", "type": "DRUG" }, { "name": "Placebo for Enlicitide", "type": "OTHER" }, { "name": "Placebo for Ezetimibe", "type": "OTHER" }, { "name": "Placebo for Bempedoic Acid", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 301, "start_date": "2024-07-08", "completion_date": "2025-03-28", "has_results": true, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 7, "location_summary": "Lincoln, California • Flossmoor, Illinois • Louisville, Kentucky + 4 more", "locations": [ { "city": "Lincoln", "state": "California" }, { "city": "Flossmoor", "state": "Illinois" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Rockville", "state": "Maryland" }, { "city": "Gulfport", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT06450366" }, { "nct_id": "NCT03193047", "title": "Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "bempedoic acid 180mg", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" }, { "name": "evolocumab", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Esperion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2017-04-07", "completion_date": "2018-02-19", "has_results": true, "last_update_posted_date": "2020-04-03", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03193047" }, { "nct_id": "NCT05263778", "title": "Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cardiovascular Diseases", "NSTEMI", "STEMI" ], "interventions": [ { "name": "Bempedoic Acid / Ezetimibe Oral Tablet", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2022-03", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2022-03-03", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 1, "location_summary": "Oakland, California", "locations": [ { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05263778" }, { "nct_id": "NCT03051100", "title": "Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Bempedoic acid 180mg", "type": "DRUG" }, { "name": "Ezetimibe 10mg", "type": "DRUG" }, { "name": "Atorvastatin 20mg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Esperion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 63, "start_date": "2017-01-19", "completion_date": "2017-07-05", "has_results": true, "last_update_posted_date": "2020-04-03", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 11, "location_summary": "Champaign, Illinois • Cary, North Carolina • Charlotte, North Carolina + 7 more", "locations": [ { "city": "Champaign", "state": "Illinois" }, { "city": "Cary", "state": "North Carolina" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Hickory", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03051100" }, { "nct_id": "NCT02659397", "title": "A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "ETC-1002", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Esperion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 68, "start_date": "2015-12", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2019-03-29", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 19, "location_summary": "Anaheim, California • Los Angeles, California • Northridge, California + 16 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02659397" }, { "nct_id": "NCT02666664", "title": "Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolemia", "Atherosclerotic Cardiovascular Diseases" ], "interventions": [ { "name": "ETC-1002", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Esperion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2230, "start_date": "2016-01-21", "completion_date": "2018-03-28", "has_results": true, "last_update_posted_date": "2020-05-11", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 48, "location_summary": "Huntsville, Alabama • Cottonwood, Arizona • Phoenix, Arizona + 45 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Cottonwood", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02666664" }, { "nct_id": "NCT05103254", "title": "Bempedoic Acid Pregnancy Surveillance Program", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pregnancy", "Hyperlipidemias" ], "interventions": [ { "name": "Bempedoic Acid", "type": "DRUG" }, { "name": "Bempedoic Acid / Ezetimibe", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Esperion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 20, "start_date": "2021-09-01", "completion_date": "2032-05", "has_results": false, "last_update_posted_date": "2024-05-17", "last_synced_at": "2026-09-02T04:30:14.926Z", "location_count": 1, "location_summary": "Morrisville, North Carolina", "locations": [ { "city": "Morrisville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05103254" } ] }